Financial Engines Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,411
| Closed | -$206K | – | 541 |
|
|
2025
Q4 | $206K | Buy |
+2,411
| New | +$198K | ﹤0.01% | 526 |
|
|
2023
Q4 | – | Sell |
-60,999
| Closed | -$4.23M | – | 327 |
|
|
2023
Q3 | $4.23M | Buy |
+60,999
| New | +$4.9M | 0.01% | 89 |
|
|
2022
Q4 | – | Sell |
-62,854
| Closed | -$5.19M | – | 298 |
|
|
2022
Q3 | $5.19M | Sell |
62,854
-1,617
| -3% | -$156K | 0.02% | 85 |
|
|
2022
Q2 | $6.13M | Buy |
64,471
+9,459
| +17% | +$979K | 0.02% | 82 |
|
|
2022
Q1 | $6.48M | Sell |
55,012
-12,937
| -19% | -$1.45M | 0.02% | 77 |
|
|
2021
Q4 | $8.8M | Buy |
+67,949
| New | +$7.93M | 0.02% | 64 |
|
|
2021
Q2 | – | Sell |
-71,641
| Closed | -$5.99M | – | 229 |
|
|
2021
Q1 | $5.99M | Sell |
71,641
-53
| -0.1% | -$4.48K | 0.02% | 66 |
|
|
2020
Q4 | $6.54M | Buy |
71,694
+23,333
| +48% | +$1.94M | 0.02% | 67 |
|
|
2020
Q3 | $3.86M | Buy |
48,361
+29,063
| +151% | +$2.27M | 0.02% | 73 |
|
|
2020
Q2 | $1.33M | Sell |
19,298
-59,719
| -76% | -$4.24M | 0.01% | 89 |
|
|
2020
Q1 | $4.97M | Buy |
79,017
+6,918
| +10% | +$499K | 0.03% | 62 |
|
|
2019
Q4 | $5.61M | Buy |
72,099
+5,334
| +8% | +$417K | 0.03% | 59 |
|
|
2019
Q3 | $4.89M | Sell |
66,765
-14,796
| -18% | -$1.04M | 0.03% | 51 |
|
|
2019
Q2 | $5.02M | Sell |
81,561
-5,112
| -6% | -$309K | 0.03% | 50 |
|
|
2019
Q1 | $5.53M | Sell |
86,673
-13,353
| -13% | -$762K | 0.03% | 47 |
|
|
2018
Q4 | $5.11M | Buy |
100,026
+11,490
| +13% | +$581K | 0.04% | 48 |
|
|
2018
Q3 | $5.14M | Buy |
88,536
+6,396
| +8% | +$313K | 0.1% | 28 |
|
|
2018
Q2 | $3.99M | Sell |
82,140
-21,381
| -21% | -$998K | 0.09% | 28 |
|
|
2018
Q1 | $4.81M | Sell |
103,521
-38,484
| -27% | -$1.67M | 0.14% | 24 |
|
|
2017
Q4 | $5.33M | Buy |
142,005
+51,921
| +58% | +$1.91M | 0.15% | 24 |
|
|
2017
Q3 | $3.28M | Buy |
+90,084
| New | +$3.44M | 0.11% | 25 |
|
|
2017
Q2 | – | Sell |
-116,262
| Closed | -$3.65M | – | 90 |
|
|
2017
Q1 | $3.65M | Buy |
116,262
+15,084
| +15% | +$472K | 0.17% | 22 |
|
|
2016
Q4 | $3.16M | Sell |
101,178
-20,103
| -17% | -$651K | 0.16% | 24 |
|
|
2016
Q3 | $4.87M | Buy |
121,281
+10,230
| +9% | +$385K | 3.89% | 9 |
|
|
2016
Q2 | $3.69M | Sell |
111,051
-16,215
| -13% | -$555K | 3.1% | 10 |
|
|
2016
Q1 | $3.74M | Buy |
127,266
+13,134
| +12% | +$362K | 3.1% | 11 |
|
|
2015
Q4 | $3M | Buy |
114,132
+21,288
| +23% | +$553K | 2.4% | 14 |
|
|
2015
Q3 | $2.2M | Sell |
92,844
-11,634
| -11% | -$281K | 1.55% | 17 |
|
|
2015
Q2 | $2.48M | Sell |
104,478
-32,526
| -24% | -$734K | 1.47% | 16 |
|
|
2015
Q1 | $2.91M | Sell |
137,004
-19,464
| -12% | -$437K | 2.47% | 12 |
|
|
2014
Q4 | $3.32M | Buy |
156,468
+720
| +0.5% | +$14.5K | 2.83% | 11 |
|
|
2014
Q3 | $2.65M | Sell |
155,748
-2,712
| -2% | -$42.8K | 2.05% | 17 |
|
|
2014
Q2 | $2.27M | Buy |
158,460
+25,002
| +19% | +$339K | 1.95% | 16 |
|
|
2014
Q1 | $1.65M | Sell |
133,458
-39,588
| -23% | -$457K | 1.35% | 22 |
|
|
2013
Q4 | $1.9M | Buy |
173,046
+56,538
| +49% | +$637K | 1.58% | 19 |
|
|
2013
Q3 | $1.35M | Buy |
116,508
+61,530
| +112% | +$720K | 1.13% | 23 |
|
|
2013
Q2 | $616K | Buy |
+54,978
| New | +$651K | 0.53% | 29 |
|
Other funds holding EW
VCM
VPM
Financial Engines Advisors's EW Position: Q1 2026 in Review
Financial Engines Advisors sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 2,411 shares — an estimated $206K sold.
Financial Engines Advisors first reported a position in EW in Q2 2013 and held it in 37 quarters. The position peaked at $8.8M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Financial Engines Advisors reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
- Financial Engines Advisors sold 2,411 Edwards Lifesciences shares in Q1 2026, an estimated $206K.
- Financial Engines Advisors first reported a position in Edwards Lifesciences in Q2 2013 and held it in 37 quarters.
- Financial Engines Advisors's Edwards Lifesciences position peaked at $8.8M in Q4 2021.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Financial Engines Advisors's 13F filing for Q1 2026, filed 14 May 2026.